It is a chemicals private limited company based in Lucknow, Uttar Pradesh, India, established in 2021.
2021 | Lucknow, Uttar Pradesh, India | ActiveVmvs Nexgen Pharmarise India Private Limited, a active private limited company, was established on 16 November 2021 in Lucknow, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100UP2021PTC155518. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.90 M.
Its leadership includes Akanksha Singh Gaur (Director), Deepti Srivastava (Director), Vivek Singh (Director). It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Mrs. Rekha Singh W/O Mr. Sarvesh Kumar 956 Kiran Enclave Kursi, Lucknow, Uttar Pradesh, 226026.
U24100UP2021PTC155518
155518
16 November 2021
₹1.50 M
₹0.90 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Vmvs Nexgen Pharmarise India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akanksha Singh Gaur | Director | 16 Nov 2021 | Current |
| Deepti Srivastava | Director | 16 Nov 2021 | Current |
| Vivek Singh | Director | 16 Nov 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Vmvs Nexgen Pharmarise India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Vmvs Nexgen Pharmarise India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2023 | State Bank Of India | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Vmvs Nexgen Pharmarise India has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vmvs Nexgen Pharmarise India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vmvs Nexgen Pharmarise India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vmvs Nexgen Pharmarise India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Vmvs Nexgen Pharmarise India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
A charge with State Bank Of India amounted to Rs. 1.00 M with Charge ID 100724798 was registered on 21 Mar 2023. was recorded as a recent event.
Akanksha Singh Gaur was appointed as a Director was appointed as a Director on 16 Nov 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.
Deepti Srivastava was appointed as a Director was appointed as a Director on 16 Nov 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.
The activity Vivek Singh was appointed as a Director was appointed as a Director on 16 Nov 2021 & has been associated with this company since 4 years 1 month . was completed.
The CIN of Vmvs Nexgen Pharmarise India Private Limited is U24100UP2021PTC155518.
Vmvs Nexgen Pharmarise India Private Limited is headquartered at Mrs. Rekha Singh W/O Mr. Sarvesh Kumar 956 Kiran Enclave Kursi, Lucknow, Uttar Pradesh, 226026.
Vmvs Nexgen Pharmarise India Private Limited was incorporated on 16 November 2021.
The current directors of Vmvs Nexgen Pharmarise India Private Limited are
The primary industry of Vmvs Nexgen Pharmarise India Private Limited is Chemicals.
Vmvs Nexgen Pharmarise India Private Limited is unlisted.
The authorized capital of Vmvs Nexgen Pharmarise India Private Limited is ₹1.50 M, and the paid-up capital is ₹0.90 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX